Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hoffmann

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Plos One|June 8, 2012
Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domainsDirk Hoffmann, Doreen Schwarck, Carina Banning, et al.
Studies in Health Technology and Informatics|June 25, 2020
Telemedical Concepts for Heart Failure Patients Treated with a Wearable Cardioverter DefibrillatorNils Reiss, Thomas Schmidt, Jan-Dirk Hoffmann, et al.
Plos One|February 25, 2010
A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cellsCarina Banning, Jörg Votteler, Dirk Hoffmann, et al.
Annals of Hematology|August 22, 2020
Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCsMalte Ritter, Maksim Klimiankou, Olga Klimenkova, et al.
The International Journal of Artificial Organs|December 19, 2019
Infrastructural needs and expected benefits of telemonitoring in left ventricular assist device therapy: Results of a qualitative study using expert interviews and focus group discussions with patientsChristin Walter, Florian Fischer, Jasmin S Hanke, et al.
Gene Therapy|February 14, 2020
Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cellsDirk Hoffmann, Johannes Kuehle, Daniela Lenz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2014
Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cellsJohannes Kuehle, Soeren Turan, Tobias Cantz, et al.
Stem Cell Reports|September 24, 2019
Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous PseudogenesDenise Klatt, Erica Cheng, Friederike Philipp, et al.
International Journal of Molecular Sciences|September 10, 2021
A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AMLJacob Jalil Hassan, Anna Lieske, Nicole Dörpmund, et al.
Biomaterials|August 22, 2015
TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cellsAnne-Kathrin Dreyer, Dirk Hoffmann, Nico Lachmann, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Plos One|June 8, 2012
Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domainsDirk Hoffmann, Doreen Schwarck, Carina Banning, et al.
Studies in Health Technology and Informatics|June 25, 2020
Telemedical Concepts for Heart Failure Patients Treated with a Wearable Cardioverter DefibrillatorNils Reiss, Thomas Schmidt, Jan-Dirk Hoffmann, et al.
Plos One|February 25, 2010
A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cellsCarina Banning, Jörg Votteler, Dirk Hoffmann, et al.
Annals of Hematology|August 22, 2020
Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCsMalte Ritter, Maksim Klimiankou, Olga Klimenkova, et al.
The International Journal of Artificial Organs|December 19, 2019
Infrastructural needs and expected benefits of telemonitoring in left ventricular assist device therapy: Results of a qualitative study using expert interviews and focus group discussions with patientsChristin Walter, Florian Fischer, Jasmin S Hanke, et al.
Gene Therapy|February 14, 2020
Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cellsDirk Hoffmann, Johannes Kuehle, Daniela Lenz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2014
Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cellsJohannes Kuehle, Soeren Turan, Tobias Cantz, et al.
Stem Cell Reports|September 24, 2019
Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous PseudogenesDenise Klatt, Erica Cheng, Friederike Philipp, et al.
International Journal of Molecular Sciences|September 10, 2021
A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AMLJacob Jalil Hassan, Anna Lieske, Nicole Dörpmund, et al.
Biomaterials|August 22, 2015
TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cellsAnne-Kathrin Dreyer, Dirk Hoffmann, Nico Lachmann, et al.
Pageof 5